Avita Medical | 1811094D - Marktkapitalisierung

Aktienkurs
1.30
Täglich Wechseln
0.02 1.80%
Monatlich
-4.89%
Jährlich
-52.79%
Q2 Prognose
1.05




Marktkapitalisierung Veränderung Datum
Clinuvel Pharmaceuticals AUD 625.5M 105.22M 2025-12
Cochlear AUD 17.05B 2.6B 2025-12
CSL USD 55.89B 20.42B 2025-12
Cspc Pharmaceutical CNY 87.29B 19.74B 2025-12
Deva Holding AS TRY 17.54B 7.76B 2023-09
Dianthus Therapeutics USD 1.78B 215M 2025-12
Divis Laboratories Ltd INR 1.7T 186.62B 2025-12
Kangmei Pharma CNY 27.93B 1.73B 2025-09
Knight Therapeutics CAD 600.53M 14.56M 2025-12
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Malin Corporation EUR 142.92M 19.65M 2026-02
Mayne Pharma AUD 252.67M 153.55M 2025-12
Medical Developments International AUD 62.53M 563.29K 2025-12
Nanosonics AUD 1.2B 25.43M 2025-12
Neuren Pharmaceuticals AUD 2.36B 606.56M 2025-12
Organigram Holdings CAD 312.16M 66.64M 2025-12
Ovoca Bio EUR 6.12M 4.93M 2026-04
Pacific Edge NZD 194.21M 87.84M 2025-12
Paradigm Biopharmaceuticals AUD 145.7M 26.92M 2025-12
Pharma Mar EUR 1.35B 283.5M 2025-12
Polynovo AUD 849.74M 24.18M 2025-12
PYC Therapeutics AUD 965.3M 209.97M 2025-12
Qiagen NV USD 9.9B 207.4M 2025-12
Ramsay Health Care AUD 7.93B 537.83M 2025-12
ResMed USD 52.52B 12.57B 2025-12
Sartorius EUR 16.41B 2.95B 2025-12
Telix Pharmaceuticals AUD 5.07B 5.81B 2025-12
Zealand Pharma A/S 33.35B 0 2026-04
Zz Pientze Pharmaceu CNY 118.73B 1.94B 2025-09